Synakis
PrivateLast Round
Pre Seed
May 26, 2026
Total Funding Raised
$2.04M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Synakis operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Pre Seed round in May 2026.
Synakis is a biotechnology company developing novel biomaterial-based treatments for ocular injuries and diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synakis Comparables
Compare Synakis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pykus Therapeutics Inc. | 90% | |
| ForSeeCon Eye Corporation | 87% | |
| Alcon | 76% |
For institutional investors. Book with your work email.
Synakis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 26, 2026 | ||||
| Accelerator | Mar 12, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Synakis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Glycomics Network | Pre Seed |
| TIAP | Pre Seed |
| Ontario Genomics | Accelerator |
| Chiefswood Private Capital Inc. | Pre Seed |
| Ontario Centre of Innovation | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 88% MoM, reaching 1K.
- May 26, 2026
$1.89M round led by TIAP and Chiefswood Private Capital.
For institutional investors. Book with your work email.
Synakis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synakis's valuation, stock price, and market status.
Is Synakis a public or private company?
Synakis is a private company.
What is the current stock price of Synakis?
Synakis is a private company, so its shares have no public market price. Caplight tracks Synakis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synakis worth (valuation)?
Valuation information for Synakis is not publicly available.
Can I buy Synakis stock?
Synakis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synakis's last funding round?
Synakis's most recent funding round was Pre Seed on May 26, 2026.
Who are the main investors in Synakis?
Key investors in Synakis include TIAP, Ontario Genomics, Chiefswood Private Capital Inc..
Will Synakis IPO soon?
No public IPO plans have been announced for Synakis.
How can I track Synakis secondary market activity?
Caplight tracks bids, offers, and trades in Synakis's shares on secondary markets.